Company intelligence / Profile preview
Nissan Chemical
- Ownership
- Private
- Employees
- ~2583
- Development stage
- Commercial
Overview
Nissan Chemical develops and commercializes chemicals, performance materials, agrochemicals, and pharmaceuticals. It manufactures proprietary drugs such as fluralaner (“BRAVECTO”) and pitavastatin (“LIVALO”), provides custom manufacturing of pharmaceutical ingredients from pre-clinical to commercial stages, and supplies advanced materials to electronics industries. The company’s healthcare segment leverages its chemical expertise to develop new pharmaceuticals while also serving as a contract manufacturer for the life sciences sector.
- Therapeutic areas
- OtherCardiovascularInfectious Diseases
- Modalities
- Small moleculeBiologicRecombinant proteinCustom synthesis services for various modalities
- Industry
- Chemicals & Materials
Drug pipeline
6 assets5 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Nissan Chemical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nissan Chemical.